1) American Cancer Society:Cancer Facts & Figures 2018.(https://www.cancer.org/research/)
2) Asmar R, Yang J, Carvajal RD:Clinical utility of nivolumab in the treatment of advanced melanoma. Ther Clin Risk Manag 12:313-325, 2016
3) Donato J, Campigotto F, Uhlmann EJ, Coletti E, Neuberg D, Weber GM, Zwicker JI:Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin:a matched cohort study. Blood 126:494-499, 2015
4) Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF:Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22:1293-1300, 2004
5) 福島 聡:免疫チェックポイント阻害剤による有害事象.Jpn J Clin Immunol 39:30-36, 2016
6) Gerber NK, Young RJ, Barker CA, Wolchok JD, Chan TA, Yamada Y, Friguglietti L, Beal K:Ipilimumab and whole brain radiation therapy for melanoma brain metastases. J Neurooncol 121:159-165, 2015
7) Ginaldi S, Wallace S, Shalen P, Luna M, Handel S:Cranial computed tomography of malignant melanoma. AJR Am J Roentgenol 136:145-149, 1981
8) Hodi FS, O' Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Pedchel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ:Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711-723, 2010
9) Komiyama M, Yagura H, Baba M, Yasui T, hakuba A, Nishimura S, Inoue Y:MR imaging:possibility of tissue characterization of brain tumors using T1 and T2 values. AJNR Am J Neuroradiol 8:65-70, 1987
10) Patel JK, Didolkar MS, Pickren JW, Moore RH:Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135:807-810, 1978
11) Tran HN, Li Y, Udaltsova N, Armstrong MA, Friedman GD, Klatsky AL:Risk of cancer in Asian Americans:a Kaiser Permanente cohort study. Cancer Causes Control 27:1197-1207, 2016
12) Weber JS, O' Day S, Urba W, Powderly J, Nichol G, Yellin M, Snively J, Hersh E:Phase Ⅰ/Ⅱ study of ipilimumab for patients with metastatic melanoma. J Clin Oncol 26:5950-5956, 2008